Alembic Pharmaceuticals receives USFDA final approval for Pirfenidone tablets
The tablets have an estimated market size of US $ 548 million for twelve months ending December 2021 according to IQVIA
The tablets have an estimated market size of US $ 548 million for twelve months ending December 2021 according to IQVIA
The key categories include intimate wellness, skincare & hair care
Dr Rupali Paranjape, an experienced regulatory and compliance consultant and author of Blue Ocean of Compliance shares insights on her book in an interview with Thomas C Thottathil, Editor, www.indianpharmapost.com
The two companies will work together for the Prospective Evaluation of OrionAI – a revolutionary AI-based Diagnostic Assistant for Histological Examination of a variety of solid tumours beginning with Head and Neck Squamous Cell Carcinoma (HNSCC) Cancer
Includes thermostabilized Ebola vaccines
‘Infinite Care’ comprises two key pillars - Sparsh Sankalpa and Sparsh Sukshema
When asked how to balance ESG with broader business goals, the panel was unanimous in its assessment that ESG is ‘good for business’
A primary investment of Rs 194.4 crore has been made
Purpose-built bioconjugation facility in Lonza’s Ibex Dedicate Biopark in Visp, Switzerland to support the potential commercial launch of Kodiak's lead product candidate KSI-301 for high-prevalence retinal diseases
The latest certification endorses product for cold chain monitoring across 194 WHO member countries
Subscribe To Our Newsletter & Stay Updated